RNAZ (TransCode Therapeutics, Inc. Common Stock) Stock Analysis - Insider Trades
TransCode Therapeutics, Inc. Common Stock (RNAZ) is a publicly traded Healthcare sector company. As of May 21, 2026, RNAZ trades at $6.35 with a market cap of $5.66M and a P/E ratio of -0.12. RNAZ moved +0.00% today. Year to date, RNAZ is -17.43%; over the trailing twelve months it is -25.12%. Its 52-week range spans $5.56 to $739.20. Rallies surfaces RNAZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading RNAZ stock inside the company?
Recent RNAZ insider activity includes Fitzgerald Thomas A bought 49.35K, Dudley Robert Michael bought 98.00K, Dudley Robert Michael bought 12.00K, Dudley Robert Michael bought 6.61K, and Dudley Robert Michael bought 19.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
RNAZ Key Metrics
Key financial metrics for RNAZ
Metric
Value
Price
$6.35
Market Cap
$5.66M
P/E Ratio
-0.12
EPS
$-52.59
Dividend Yield
0.00%
52-Week High
$739.20
52-Week Low
$5.56
Volume
0
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-34.66M
Gross Margin
0.00%
Recent RNAZ Insider Trades
Fitzgerald Thomas A bought 49.35K (~$25.17K) on Sep 28, 2023.
Dudley Robert Michael bought 98.00K (~$49.98K) on Sep 28, 2023.
Dudley Robert Michael bought 12.00K (~$31.82K) on Jun 21, 2023.
Dudley Robert Michael bought 6.61K (~$16.85K) on Jun 20, 2023.
Dudley Robert Michael bought 19.00K (~$52.44K) on Jun 9, 2023.
RNAZ analyst coverage data. Average price target: $0.00.
Common questions about RNAZ
Who is trading RNAZ stock inside the company?
Recent RNAZ insider activity includes Fitzgerald Thomas A bought 49.35K, Dudley Robert Michael bought 98.00K, Dudley Robert Michael bought 12.00K, Dudley Robert Michael bought 6.61K, and Dudley Robert Michael bought 19.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for RNAZ?
Yes. Rallies tracks RNAZ insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is RNAZ research on Rallies investment advice?
No. Rallies provides research, data, and educational context for RNAZ. It does not provide personalized investment advice.
